Interest of Learning Self-hypnosis for Patients Awaiting Lung Transplantation

Lung Diseases Clinical Trial

— AUTOHYPNOSE-TP  

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02216539
• Other study ID #: 2014-A00538-39
• Status: Terminated
• Phase: N/A
• First received: August 13, 2014
• Last updated: May 12, 2016
• Start date: July 2014

Study information

• Verified date: May 2016
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Agence Nationale de Sécurité du Médicament et des produits de santé
• Study type: Interventional

Clinical Trial Summary

Patients benefitting from a lung transplantation are subject to long-lasting and often severe post-operative pain. Self-hypnosis has been proven effective in the management of acute pain.

The study hypothesis is that pre-operative training in self-hypnosis given to patients awaiting lung transplantation, will result in a reduction of post-operative pain one month after surgery.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 5
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 15 Years to 90 Years

Eligibility

Inclusion Criteria:

• patients over 15 years of age

• indication of lung transplantation

Exclusion Criteria:

• patient unable to receive training in self-hypnosis (for cognitive, linguistic or cultural reasons)

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Lung Diseases

Intervention

Behavioral:
• Self-hypnosis
Patients will be trained to self-hypnosis prior to surgery, in order to be able to use self-hypnosis as a pain-management tool after surgery

Procedure:
• Lung transplantation

Other:
• Standard post-operative pain management
Post-operative pain management treatments as per usual protocols in the hospital

Locations

Country	Name	City	State
France	Hôpital Foch	Suresnes

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Average Pain Score (Visual Analog Scale) One Month After Surgery	Average level of pain (scored by the patient on a visual analog scale), during the 48 hours preceding the scheduled consultation at one month post-surgery	one month after transplantation	No